✦ LIBER ✦

Breast cancer and the immune response

✍ Scribed by D. E. H. Tee; K. W. Pettingale

Publisher: John Wiley and Sons
Year: 1974
Tongue: English
Weight: 269 KB
Volume: 61
Category: Article
ISSN: 0007-1323
DOI: 10.1002/bjs.1800611008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reevaluation of the cellular immune resp

Reevaluation of the cellular immune response in breast cancer patients vaccinated with MUC1

✍ Cristina Musselli; Govindaswami Ragupathi; Teresa Gilewski; Katherine S. Panagea 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 114 KB

## Abstract Conjugation of antigens to a carrier protein like keyhole limpet hemocyanin (KLH) has proven effective in clinical trials for inducing antibodies against selected tumor antigens. The impact of this approach on T‐cell immunity has not been previously tested. We utilized peripheral blood

Profiling the immune response in patient

Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries

✍ Mouldy Sioud; Mona H. Hansen 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 2 views

Radiotherapy in the postoperative treatm

Radiotherapy in the postoperative treatment of operable cancer of the breast. Part II. A re-examination of Stjernswärd's application of the mantel-haenszel statistical method. Evaluation of the effect of the radiation on immune response and suggestions for postoperative radiotherapy

✍ Professor Seymour H. Levitt; Richard B. McHugh; Chang W. Song 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 756 KB

A re-examination of the statistical methods used to develop the claim that radiation postoperatively decreases survival was carried out. This study demonstrates that a) when correct figures are used, statistical significance is not demonstrated, i.e. there is not statistically significant evidence t

Does [meso-1,2-bis(2,6-dichloro-4-hydrox

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloroplatinum (II) Act on the Hormone-Sensitive, Murine Breast Cancer as a Biological Response Modifier? Part II. Studies on the Influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) on the Specific Immune Defense in MXT-M-3,2 Breast Cancer Bearing Mice

✍ Richard Schlemmer; Thilo Spruß; Günther Bernhardt; Helmut Schönenberger 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 1 views

Does [meso-1,2-Bis(2,6-dichloro-4-hydrox

Does [meso-1,2-Bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]-dichloro-platinum(II) Act as an Immune Response Modifier? Part III: Progressively Growing MXT-M-3,2 Breast Cancer Stimulates the Proliferation of Phagocytes in B6D2F1 Mice

✍ Richard Schlemmer; Thilo Spruß; Günther Bernhardt; Helmut Schönenberger 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 1 views

Does [meso-1,2-bis(2,6-dichloro-4-hydrox

Does [meso-1,2-bis(2,6-dichloro-4-hydroxy-phenyl) ethylenediamine]dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound

✍ Richard Schlemmer; Thilo Spruß; Günther Bernhardt; Helmut Schönenberger 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 303 KB 👁 1 views